Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Canine hair follicles have stem cells in the bulge region.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

UV light helped human hair transplants survive in mice without broad immunosuppression.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

CD133+ cells are crucial for hair growth.

CD90 is abundantly present on stem-like cells in dog hair follicles.

CD34 is crucial for skin tumor development in mice.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Stem cells help control the immune response to improve wound healing.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

CD2 might be a new treatment target for patchy alopecia areata.

CD44 variant changes start alopecia areata, but don't maintain it.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.